Anti-GPRC5D CAR-T Therapy Elicits Responses After Anti-BCMA CAR Failure
Anti-GPRC5D CAR T-cell therapy can produce responses in patients with relapsed or refractory multiple myeloma, a phase 2 trial suggests.
Diagnosis & Disease Information
Antimicrobial Stewardship Team Improved Use of Carbapenem in Hematology Patients
A study sought to determine the effect of an antimicrobial stewardship team on carbapenem therapy in patients with hematologic disorders.
Update on Therapeutic Options for Myelofibrosis
A review of myelofibrosis, including an update on treatment options, was presented at the 2023 ONA Summit.
Treatment Selection and Symptom Management After MDS/MDN Diagnosis
A review of MDS/MDN, including new WHO guidelines and collaborative strategies for managing the care of patients with lower-risk MDS.
Achieving, Managing Patient Care During Maintenance Therapy for AML
The unique needs of patients with AML undergoing maintenance therapy, including care disparities and challenges, are discussed at the 2023 ONA Summit.
CAR-T Survival Outcomes Unrelated to Household Poverty and Neighborhood Opportunity in ALL
Researchers sought to determine whether OS rates with CAR-T therapy were linked to household poverty and neighborhood opportunity for patients with ALL.
Factors Linked to Worse CAR-T Outcomes in High-Risk Multiple Myeloma
High-risk cytogenetics and extramedullary disease may be associated with worse survival outcomes of CAR T-cell therapy in relapsed or refractory multiple myeloma, a meta-analysis suggests.
Risk of Cardiovascular Toxicity With Proteasome Inhibitor Therapy for Multiple Myeloma
Researchers outlined risks, mechanisms, and possible strategies related to cardiovascular toxicity with proteasome inhibitors for multiple myeloma therapy.
Sexual Health and Cancer: What Providers Need to Know
Sexual dysfunction may be common in cancer patients and survivors, but their sexual health is often overlooked.
5 Factors That May Affect Multiple Myeloma Outcomes
What are some of the most important factors affecting outcomes in patients with multiple myeloma?
- Loading...
Loading...
Next post in Multiple Myeloma
Loading... 
Loading...